Glycopyrronium bromide

Cuvposa, Glyrx-pf, Lonhala Magnair Kit, Robinul, Robinul Forte, Seebri (glycopyrrolate) is a small molecule pharmaceutical. Glycopyrrolate was first approved as Cuvposa on 1982-01-01. It is used to treat drug-induced abnormalities, peptic ulcer, and respiratory tract diseases in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M5, muscarinic acetylcholine receptor M1, muscarinic acetylcholine receptor M4, muscarinic acetylcholine receptor M3, and muscarinic acetylcholine receptor M2.